Letters to the Editor
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren’s syndrome treated with rituximab: a possible role for glandular BAFF
F. Carubbi1, P. Cipriani2, P. Di Benedetto3, P. Ruscitti4, A. Alunno5, R. Gerli6, R. Giacomelli7
- Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy; and Department of Medicine, ASL 1 Avezzano-Sulmona-L’Aquila, Italy. francescocarubbi@libero.it
- Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.
- Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.
- Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.
- Department of Medicine, Rheumatology Unit, University of Perugia, Italy.
- Department of Medicine, Rheumatology Unit, University of Perugia, Italy.
- Department of Biotechnological and Applied Clinical Sciences, Rheumatology Unit, University of L’Aquila, Italy.
CER9090
2016 Vol.34, N°6
PI 1123, PF 1124
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 27494407 [PubMed]
Received: 02/11/2015
Accepted : 17/02/2016
In Press: 02/08/2016
Published: 28/11/2016
